GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-30
DOI
10.3389/fimmu.2018.01062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Posttransplant chimeric antigen receptor therapy
- (2018) Melody Smith et al. BLOOD
- Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
- (2018) Maaike V. J. Braham et al. OncoImmunology
- Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use
- (2017) Dominik Lock et al. HUMAN GENE THERAPY
- Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
- (2017) Daniel T. MacLeod et al. MOLECULAR THERAPY
- Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation
- (2017) Siyi Gu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global Manufacturing of CAR T Cell Therapy
- (2017) Bruce L. Levine et al. Molecular Therapy-Methods & Clinical Development
- Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response
- (2017) Qiong Xue et al. Journal for ImmunoTherapy of Cancer
- RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
- (2016) Zsolt Sebestyen et al. Cell Reports
- Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer
- (2015) T. Straetemans et al. CLINICAL CANCER RESEARCH
- Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
- (2015) D Sommermeyer et al. LEUKEMIA
- Requirements for Effective Antitumor Responses of TCR Transduced T Cells
- (2014) M. A. de Witte et al. JOURNAL OF IMMUNOLOGY
- Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype
- (2014) Raquel Gomez-Eerland et al. Human Gene Therapy Methods
- Hunting for clinical translation with innate-like immune cells and their receptors
- (2013) W Scheper et al. LEUKEMIA
- Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
- (2013) Wouter Scheper et al. OncoImmunology
- 9 and 2CDR3 domains regulate functional avidity of T cells harboring 9 2TCRs
- (2012) C. Grunder et al. BLOOD
- Redirecting T cells against cancer cells by transfer of a broadly tumor-reactive T-cell receptor
- (2011) V. Marcu-Malina et al. BLOOD
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficient Human Hematopoietic Cell Transduction Using RD114- and GALV-Pseudotyped Retroviral Vectors Produced in Suspension and Serum-Free Media
- (2009) Karim Ghani et al. HUMAN GENE THERAPY
- T-Cell Receptor Gene Therapy of Established Tumors in a Murine Melanoma Model
- (2009) John D. Abad et al. JOURNAL OF IMMUNOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started